298 results on '"Colarossi, Cristina"'
Search Results
2. Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer
3. Recapitulating thyroid cancer histotypes through engineering embryonic stem cells
4. SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection
5. Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression
6. The Protective Role of Troxerutin (Trox) in Counteracting Anaplastic Thyroid Carcinoma (ATC) Progression.
7. Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15, 2796
8. Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology
9. ARID1A Mutations in Gastric Cancer: A Review with Focus on Clinicopathological Features, Molecular Background and Diagnostic Interpretation.
10. Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology.
11. Interleukin-21 Influences Glioblastoma Course: Biological Mechanisms and Therapeutic Potential
12. History of Immunohistochemistry
13. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC)
14. Data from Assessment of MAGE-A Expression in Resected Non–Small Cell Lung Cancer in Relation to Clinicopathologic Features and Mutational Status of EGFR and KRAS
15. Supplementary Figure 1 from Assessment of MAGE-A Expression in Resected Non–Small Cell Lung Cancer in Relation to Clinicopathologic Features and Mutational Status of EGFR and KRAS
16. Supplementary Table 2 from Assessment of MAGE-A Expression in Resected Non–Small Cell Lung Cancer in Relation to Clinicopathologic Features and Mutational Status of EGFR and KRAS
17. Supplementary Table 1 from Assessment of MAGE-A Expression in Resected Non–Small Cell Lung Cancer in Relation to Clinicopathologic Features and Mutational Status of EGFR and KRAS
18. Bone Abnormalities in Latent TGF-β Binding Protein (Ltbp)-3-Null Mice Indicate a Role for Ltbp-3 in Modulating TGF-β Bioavailability
19. Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value
20. Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies
21. Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis
22. Sodium Propionate Contributes to Tumor Cell Growth Inhibition through PPAR-γ Signaling
23. The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors
24. Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy
25. Second Primary Cancers following Colorectal Cancer in Sicily, Italy
26. Third- and Late Line Treatments of Metastatic Gastric Cancer: Still More to Be Done
27. Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness
28. The Long and Winding Road: An Overview of the Immunological Landscape of Intracranial Meningiomas
29. Cancer in Migrants: A Population-Based Study in Italy.
30. CD200 expression in patients with Multiple Myeloma: Another piece of the puzzle
31. Ex Vivo Irradiation of Lung Cancer Stem Cells Identifies the Lowest Therapeutic Dose Needed for Tumor Growth Arrest and Mass Reduction In Vivo
32. Splenic rupture following lenograstim in post-autologous stem cell transplantation treated with emergency open splenectomy: a case report and literature review
33. Sodium Propionate Contributes to Tumor Cell Growth Inhibition through PPAR-γ Signaling.
34. A Case of Non-Irradiated Balloon Cell Melanoma of the Choroid: Expanding the Morphological Spectrum of Primary Uveal Melanomas
35. Metabolic complete tumor response in a patient with epidermal growth factor receptor mutant non-small cell lung cancer treated with a reduced dose of afatinib
36. Efficacy of High-Ozonide Oil in Prevention of Cancer Relapses Mechanisms and Clinical Evidence
37. Glioblastoma, IDH-Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review
38. Lansoprazole-induced microscopic colitis: An increasing problem? Results of a prospecive case-series and systematic review of the literature
39. NF-κB localization in multiple myeloma plasma cells and mesenchymal cells
40. Targeting Phosphatases and Kinases: How to Checkmate Cancer
41. Identification by MicroRNA Analysis of Environmental Risk Factors Bearing Pathogenic Relevance in Non-Smoker Lung Cancer
42. Medullary Carcinoma of the Gastrointestinal Tract: Report on Two Cases with Immunohistochemical and Molecular Features
43. Cancer Stem Cell Biomarkers Predictive of Radiotherapy Response in Rectal Cancer: A Systematic Review
44. Clear Cell Carcinoma Arising in an Abdominal Wall Cesarean Section Scar: A Case Report With Description of Pathological and Molecular Features
45. TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells
46. Sclerosing Mesenteritis, a Rare Cause of Mesenteric Mass in a Young Adult: A Case Report
47. Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma
48. Role of miRNA-19a in Cancer Diagnosis and Poor Prognosis
49. Endomyometriosis of the Rectum With Disseminated Peritoneal Leiomyomatosis 8 Years After Laparoscopic Myomectomy: A Case Report
50. Immunomodulatory Effect of Microglia-Released Cytokines in Gliomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.